Homeostasis in Adult Vessels
成人血管的稳态
基本信息
- 批准号:9198964
- 负责人:
- 金额:$ 38.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-12-01 至 2019-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The long term goal of this line of investigation is to identify the factors that can provide inherent protection to the endothelium during the initial stages of atherosclerosis and inflammation. In this proposal, we will focus on NOTCH1, a cell surface receptor and transcription factor that, based on preliminary data, provides an anti-inflammatory phenotype to quiescent (homeostatic) endothelium. NOTCH1 is constitutively expressed by the adult endothelium of mouse and human vessels in vivo. Reduction of NOTCH1 transcripts in human endothelium in vitro or genetic inactivation of Notch1 in mice triggers an inflammatory response in the absence of any additional insult. Exposure of endothelial cells to Western diet, oxidized phospholipids (Ox- PAPC), as well as inflammatory cytokines, results in a rapid reduction in endogenous NOTCH1 (together with its target genes). Using microarray analyses of endothelial cells from 147 human donors, we observed differences in basal and Ox-PAPC treated levels of NOTCH1 and identified a locus that was associated with the response of endothelial cells to NOTCH1 by Ox-PAPC. This same locus was also associated with HDL levels in a large scale GWAS including 100,000 humans. Studies in this project will test the hypothesis that reduction of NOTCH1 by circulating lipids contributes
to the prolonged inflammation typical of atherosclerosis lesions. In fact, reduction of NOTCH1 levels in an athero-susceptible background (Apoe or Ldlr null mice) promotes acceleration of atherosclerosis and results in larger lesions. Furthermore, genetic inactivation of Notch1 in the endothelium of adult mice leads to leukocyte infiltration, detachment and loss of endothelial cells
from the intima. In addition and consistent with a role in endothelial homeostasis and suppression of inflammation, using a ChIP approach we found that NOTCH1 regulates tristetraprolin, an RNA binding protein that targets to AREs sequences in the 3'UTR causing destabilization of mRNAs encoding a cohort of inflammatory cytokines. The central hypothesis of this application is that NOTCH1 in the endothelium is essential to maintain an anti-inflammatory interface between blood and tissue. To test this hypothesis, we propose two specific aims: 1. To determine the mechanism(s) that control NOTCH1 expression and function in adult arterial endothelium; and 2. To identify the molecular pathways by which NOTCH1 maintains an anti-inflammatory status in the endothelium of quiescent arteries.
描述(由适用提供):这一调查线的长期目标是确定可以在动脉粥样硬化和炎症的初始阶段为实地提供固有保护的因素。在此提案中,我们将重点介绍Notch1,即细胞表面受体和转录因子,基于初步数据,它为静态(稳态)冬季提供了抗炎表型。 Notch1由小鼠和人体内的成年植物植物组成性表达。在没有任何其他侮辱的情况下,小鼠的体外或遗传失活的Notch1转录本在体外或遗传失活中会触发炎症反应。接触森林细胞对西方饮食,氧化磷脂(OX-PAPC)以及炎性细胞因子的暴露导致内源性Notch1(以及其靶基因)迅速降低。使用来自147名人类供体的内皮细胞的微阵列分析,我们观察到基本和OXPAPC处理的Notch1水平的差异,并确定了与OXPAPC对内皮细胞对Notch1响应的响应相关的基因座。同样的基因座也与包括100,000人在内的大规模GWA中的HDL水平有关。该项目的研究将检验以下假设:循环脂质减少Notch1的假设有助于
到典型的动脉粥样硬化病变的长时间炎症。实际上,在可动脉粥样硬化的背景(APOE或LDLR无效小鼠)中降低Notch1水平会促进动脉粥样硬化的加速,并导致较大的病变。此外,成年小鼠内皮中Notch1的遗传失活导致白细胞浸润,脱落和内皮细胞的丧失
来自内饰。此外,使用芯片方法,我们发现Notch1调节Tristetraprolin是一种靶向3'UTR中Ares序列的RNA结合蛋白,并与3'UTR的RNA结合蛋白进行调节,并与炎症方法的作用一致,并且抑制了炎症性的抑制作用。该应用的中心假设是,内皮中的Notch1对于维持血液和组织之间的抗炎界面至关重要。为了检验这一假设,我们提出了两个具体目的:1。确定控制成年动脉内皮中Notch1表达和功能的机制; 2。确定Notch1在静态动脉内皮中保持抗炎状态的分子途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
M. LUISA IRUELA-A...的其他基金
REWIRING CANCER-INDUCED ABNORMALITIES IN THE VASCULAR BARRIER
重塑血管屏障中癌症引起的异常
- 批准号:1091575210915752
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Underlying Mechanisms in Angiosarcoma
血管肉瘤的潜在机制
- 批准号:1005816710058167
- 财政年份:2020
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Underlying Mechanisms in Angiosarcoma
血管肉瘤的潜在机制
- 批准号:93012919301291
- 财政年份:2015
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Underlying Mechanisms in Angiosarcoma
血管肉瘤的潜在机制
- 批准号:90872119087211
- 财政年份:2015
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy
癌症治疗中靶向 VEGF 介导的肿瘤血管生成
- 批准号:87197908719790
- 财政年份:2014
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
16th Annual International Vascular Biology Meeting
第 16 届国际血管生物学年会
- 批准号:79159817915981
- 财政年份:2010
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
相似海外基金
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
通过描绘基因 3 端 DNA 甲基化功能,全面了解癌症的表观遗传脆弱性
- 批准号:1076536510765365
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:1061983110619831
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:1066875410668754
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
New cell biology tools to study myelin development, dynamics, and disease
研究髓磷脂发育、动力学和疾病的新细胞生物学工具
- 批准号:1064918410649184
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:1073566210735662
- 财政年份:2023
- 资助金额:$ 38.5万$ 38.5万
- 项目类别: